Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023;10(4):1367–401.

Article  CAS  PubMed  Google Scholar 

Ciciola P, Cascetta P, Bianco C, Formisano L, Bianco R. Combining immune checkpoint inhibitors with anti-angiogenic agents. J Clin Med. 2020. https://doi.org/10.3390/jcm9030675.

Article  PubMed  PubMed Central  Google Scholar 

Smahel M. PD-1/PD-L1 blockade therapy for tumors with downregulated MHC class I expression. Int J Mol Sci. 2017;18(6):1331.

Article  PubMed  PubMed Central  Google Scholar 

Banday AH, Abdalla M. Immune checkpoint inhibitors: recent clinical advances and future prospects. Curr Med Chem. 2023;30(28):3215–37.

Article  CAS  PubMed  Google Scholar 

Davies M. How checkpoint inhibitors are changing the treatment paradigm in solid tumors: what advanced practitioners in oncology need to know. J Adv Pract Oncol. 2016;7(5):498–509.

PubMed  PubMed Central  Google Scholar 

Khosroshahi LM, Parhizkar F, Kachalaki S, Aghebati-Maleki A, Aghebati-Maleki L. Immune checkpoints and reproductive immunology: pioneers in the future therapy of infertility related disorders? Int Immunopharmacol. 2021;99:107935.

Article  Google Scholar 

Reck M, Heigener D, Reinmuth N. Immunotherapy for small-cell lung cancer: emerging evidence. Future Oncol. 2016;12(7):931–43.

Article  CAS  PubMed  Google Scholar 

Saki N, Haybar H, Aghaei M. Subject: Motivation can be suppressed, but scientific ability cannot and should not be ignored. J Transl Med. 2023;21(1):520.

Article  PubMed  PubMed Central  Google Scholar 

Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023;8(1):198.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saman H, Raza SS, Uddin S, Rasul K. Inducing angiogenesis, a key step in cancer vascularization, and treatment approaches. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12051172.

Article  PubMed  Google Scholar 

Mardi A, Shirokova AV, Mohammed RN, Keshavarz A, Zekiy AO, Thangavelu L, et al. Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; combination of oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell Int. 2022;22(1):168.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao F, Yang C. Anti-VEGF/VEGFR2 monoclonal antibodies and their combinations with PD-1/PD-L1 inhibitors in clinic. Curr Cancer Drug Targets. 2020;20(1):3–18.

Article  CAS  PubMed  Google Scholar 

Brest P, Mograbi B, Pages G, Hofman P, Milano G. Checkpoint inhibitors and anti-angiogenic agents: a winning combination. Br J Cancer. 2023;129(9):1367–72.

Article  PubMed  PubMed Central  Google Scholar 

Hermel DJ, Ott PA. Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma. Cancer Metastasis Rev. 2017;36(1):43–50.

Article  CAS  PubMed  Google Scholar 

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl j Med. 1971;285(21):1182–6.

Article  CAS  PubMed  Google Scholar 

Eichhorn ME, Kleespies A, Angele M, Jauch K-W, Bruns C. Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbecks Arch Surg. 2007;392:371–9.

Article  CAS  PubMed  Google Scholar 

Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27(1):563–84.

Article  CAS  PubMed  Google Scholar 

Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis. 2007;2(1):251–75.

Article  CAS  Google Scholar 

Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58–62.

Article  CAS  PubMed  Google Scholar 

Phng L-K, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16(2):196–208.

Article  CAS  PubMed  Google Scholar 

Betz C, Lenard A, Belting H-G, Affolter M. Cell behaviors and dynamics during angiogenesis. Development. 2016;143(13):2249–60.

Article  CAS  PubMed  Google Scholar 

Ziyad S, Iruela-Arispe ML. Molecular mechanisms of tumor angiogenesis. Genes Cancer. 2011;2(12):1085–96.

Article  PubMed  PubMed Central  Google Scholar 

Li SQ, Yang Y, Ye LS. Angiogenesis and immune checkpoint dual blockade: opportunities and challenges for hepatocellular carcinoma therapy. World J Gastroenterol. 2022;28(42):6034–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng W, Qian C, Tang Y, Yang C, Zhou Y, Shen P, et al. Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade. Front Immunol. 2022;13:1035323.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aghajani M, Jalilzadeh N, Aghebati-Maleki A, Yari A, Tabnak P, Mardi A, et al. Current approaches in glioblastoma multiforme immunotherapy. Clin Transl Oncol. 2024;26(7):1584–612.

Article  PubMed  Google Scholar 

Yu P, Wang Y, Yuan D, Sun Y, Qin S, Li T. Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. Front Immunol. 2023;14:1276694.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Q, Shao D. Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers. Front Immunol. 2024;15:1487610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burrell K, Zadeh G. Molecular mechanisms of tumor angiogenesis. Tumor Angiogenesis. 2012;744(296).

Szade A, Grochot-Przeczek A, Florczyk U, Jozkowicz A, Dulak J. Cellular and molecular mechanisms of inflammation-induced angiogenesis. IUBMB Life. 2015;67(3):145–59.

Article  CAS  PubMed  Google Scholar 

Aspriţoiu VM, Stoica I, Bleotu C, Diaconu CC. Epigenetic regulation of angiogenesis in development and tumors progression: potential implications for cancer treatment. Front Cell Dev Biol. 2021;9:689962.

Article  PubMed  PubMed Central  Google Scholar 

Aghaei M, Khademi R, Far MAJ, Bahreiny SS, Mahdizade AH, Amirrajab N. Genetic variants of Dectin-1 and their antifungal immunity impact in hematologic malignancies: a comprehensive systematic review. Curr Res Transl Med. 2024;74(4):103460.

Google Scholar 

Messmer JM, Thommek C, Piechutta M, Venkataramani V, Wehner R, Westphal D, et al. T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels. Immunity. 2024;57(11):2688-703.e11.

Article  CAS  PubMed  Google Scholar 

Ghosh LD, Mathur T, Tronolone JJ, Chuong A, Rangel K, Corvigno S, et al. Angiogenesis-enabled human ovarian tumor microenvironment-chip evaluates pathophysiology of platelets in microcirculation. Adv Healthc Mater. 2024;13(19):2304263.